Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Personalized Medicine

PUBLISHER: Grand View Research | PRODUCT CODE: 2067687

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2067687

Precision Medicine Market Size, Share & Trends Analysis Report By Application (Diagnostics, Therapeutics), By End Use (Home Care, Hospitals, Clinical Laboratories), By Region (Asia Pacific, North America), And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Precision Medicine Market Summary

The global precision medicine market size was estimated at USD 116,575.36 million in 2025 and is projected to reach USD 405,106.04 million by 2033, growing at a CAGR of 16.99% from 2026 to 2033. The industry is characterized by a high degree of innovation and technological convergence, with advancements in genomics, molecular diagnostics, and data analytics playing a central role in shaping market evolution.

The integration of multi-omics data, clinical information, and real-world evidence is enabling a more comprehensive understanding of disease mechanisms and patient variability, supporting the development of highly targeted treatment strategies.

In addition, the increasing adoption of companion diagnostics and biomarker-based approaches is strengthening the integration between diagnostics and therapeutics, enabling more precise patient selection and improved treatment outcomes. The market is also witnessing significant strategic activity, including collaborations, partnerships, and acquisitions among biotechnology companies, pharmaceutical manufacturers, diagnostic providers, and technology firms aimed at expanding product portfolios, research capabilities, and geographic reach. Furthermore, evolving regulatory frameworks are supporting the development and commercialization of personalized therapies by establishing standards for safety, efficacy, and clinical validation of advanced diagnostic technologies.

The growing adoption of cloud computing, digital health platforms, and advanced bioinformatics solutions is further accelerating the growth of the industry. Healthcare providers, research institutions, and life sciences companies are increasingly leveraging integrated digital ecosystems to efficiently manage, analyze, and interpret large volumes of genomic and clinical data. The use of predictive modeling and advanced analytical tools is improving patient stratification, disease risk assessment, and therapy optimization, enabling more accurate and timely clinical decision-making. In addition, rising investments in precision oncology, rare disease therapeutics, and population genomics initiatives are supporting the development of individualized treatment pathways based on patient-specific genetic profiles. Expanding interoperability between healthcare systems, genomic databases, and digital diagnostic platforms is also improving data accessibility and clinical integration. As technological capabilities continue to advance and adoption increases across healthcare systems, the industry is expected to witness sustained expansion over the forecast period.

The industry is characterized by a high degree of innovation and technological convergence, with advancements in genomics, artificial intelligence, and data analytics playing a central role in shaping its evolution. The integration of multi-omics data, clinical information, and real-world evidence is enabling a more comprehensive understanding of disease pathways and patient variability. In addition, the increasing adoption of companion diagnostics and biomarker-based approaches is strengthening the linkage between diagnostics and therapeutics, allowing for more targeted treatment selection. The market is also witnessing strong strategic activity, including collaborations, partnerships, and acquisitions among biotechnology firms, pharmaceutical companies, and diagnostic providers to expand capabilities and geographic presence. Furthermore, regulatory frameworks are evolving to support the development and commercialization of personalized therapies, ensuring the safety, efficacy, and standardization of advanced diagnostic tools.

The growing adoption of cloud computing, digital health platforms, and advanced bioinformatics solutions is further accelerating the expansion of the industry. Healthcare providers and research organizations are increasingly leveraging integrated digital ecosystems to manage and interpret large volumes of genomic and clinical data more efficiently. The use of predictive analytics and machine learning algorithms is enhancing patient stratification, disease risk assessment, and therapy optimization, enabling more precise and timely clinical interventions. In addition, rising investments in precision oncology, rare disease research, and population genomics initiatives are supporting the development of customized treatment pathways tailored to individual genetic profiles. As interoperability between healthcare systems and genomic databases continues to improve, the ability to deliver scalable and data-driven personalized healthcare solutions is expected to strengthen significantly over the forecast period.

Global Precision Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global precision medicine market report based on application, end use, and region:

  • Application Outlook (Revenue, USD Million; 2021 - 2033)
  • Diagnostics
    • Genetic Tests
    • Direct to Consumer Tests
    • Esoteric Tests
    • Others
  • Therapeutics
    • Pharmaceuticals
    • Oncology
    • Respiratory Diseases
    • Skin Diseases
    • CNS Disorders
    • Immunology
    • Genetic Diseases
    • Others
    • Medical Devices
    • Others
  • End-use Outlook (Revenue, USD Million; 2021 - 2033)
  • Home Care
  • Hospitals
  • Clinical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE
Show more
Product Code: GVR-2-68038-612-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Precision Medicine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Precision Medicine Market: Application Business Analysis

  • 4.1. Application Market Share, 2025 & 2033
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Diagnostics
    • 4.4.1. Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.4.2. Genetic Testing
      • 4.4.2.1. Genetic Testing Market, 2021 - 2033 (USD Million)
    • 4.4.3. Direct to Consumer Tests
      • 4.4.3.1. Direct to Consumer Tests Market, 2021 - 2033 (USD Million)
    • 4.4.4. Esoteric Tests
      • 4.4.4.1. Esoteric Tests Market, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market, 2021 - 2033 (USD Million)
  • 4.5. Therapeutics
    • 4.5.1. Therapeutics Market, 2021 - 2033 (USD Million)
    • 4.5.2. Pharmaceuticals
      • 4.5.2.1. Pharmaceuticals Market, 2021 - 2033 (USD Million)
      • 4.5.2.2. Oncology
        • 4.5.2.2.1. Oncology Market, 2021 - 2033 (USD Million)
      • 4.5.2.3. Respiratory Disease
        • 4.5.2.3.1. Respiratory Disease Market, 2021 - 2033 (USD Million)
      • 4.5.2.4. Skin Disease
        • 4.5.2.4.1. Skin Disease Market, 2021 - 2033 (USD Million)
      • 4.5.2.5. CNS Disorders
        • 4.5.2.5.1. CNS Disorders Market, 2021 - 2033 (USD Million)
      • 4.5.2.6. Immunology
        • 4.5.2.6.1. Immunology Market, 2021 - 2033 (USD Million)
      • 4.5.2.7. Genetic Disease
        • 4.5.2.7.1. Genetic Disease Market, 2021 - 2033 (USD Million)
      • 4.5.2.8. Others
        • 4.5.2.8.1. Others Market, 2021 - 2033 (USD Million)
    • 4.5.3. Medical Devices
      • 4.5.3.1. Medical Devices Market, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Precision Medicine Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2025 & 2033
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 5.4. Home Care
    • 5.4.1. Home Care Market, 2021 - 2033 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market, 2021 - 2033 (USD Million)
  • 5.6. Clinical Laboratories
    • 5.6.1. Clinical Laboratories Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Precision Medicine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. Canada Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. UK Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Brazil Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. Argentina Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. Middle East & Africa Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Precision Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. F. Hoffmann-La Roche Ltd
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Siemens
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Janssen Global Services, LLC
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Illumina, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Quest Diagnostics Incorporated
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. 23andMe, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. NeoDiagnostix
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Myriad Genetics
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Medtronic
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. GE Healthcare
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Abbott
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. QIAGEN
      • 7.5.12.1. Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives
Show more
Product Code: GVR-2-68038-612-7

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global precision medicine market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 5. Global precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 6. North America precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 8. North America precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 9. U.S. precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 10. U.S. precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 11. Canada precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 12. Canada precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 13. Mexico precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 14. Mexico precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 15. Europe precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 16. Europe precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 17. Europe precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 18. UK precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 19. UK precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 20. Germany precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 21. Germany precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 22. France precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 23. France precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 24. Italy precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 25. Italy precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 26. Spain precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 27. Spain precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 28. Norway precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 29. Norway precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 30. Denmark precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 31. Denmark precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 32. Sweden precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 33. Sweden precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 36. Asia Pacific precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 37. Japan precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 38. Japan precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 39. China precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 40. China precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 41. India precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 42. India precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 43. Australia precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 44. Australia precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 45. South Korea precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 46. South Korea precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 47. Thailand precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 48. Thailand precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 49. Latin America precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 50. Latin America precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 51. Latin America precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 52. Brazil precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 53. Brazil precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Argentina precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 55. Argentina precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa precision medicine market, by country, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 58. Middle East & Africa precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 59. South Africa precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 60. South Africa precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 62. Saudi Arabia precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 63. UAE precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 64. UAE precision medicine market, by end use, 2021 - 2033 (USD Million)
  • Table 65. Kuwait precision medicine market, by application, 2021 - 2033 (USD Million)
  • Table 66. Kuwait precision medicine market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Precision medicine market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Precision medicine market dynamics
  • Fig. 11 Precision medicine market: Porter's five forces analysis
  • Fig. 12 Precision medicine market: PESTLE analysis
  • Fig. 13 Application market, 2021 - 2033 (USD Million)
  • Fig. 14 Diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 15 Genetic testing market, 2021 - 2033 (USD Million)
  • Fig. 16 Direct to consumer tests market, 2021 - 2033 (USD Million)
  • Fig. 17 Esoteric tests market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 20 Pharmaceuticals market, 2021 - 2033 (USD Million)
  • Fig. 21 Oncology market, 2021 - 2033 (USD Million)
  • Fig. 22 Respiratory disease market, 2021 - 2033 (USD Million)
  • Fig. 23 Skin diseases market, 2021 - 2033 (USD Million)
  • Fig. 24 CNS disorders market, 2021 - 2033 (USD Million)
  • Fig. 25 Immunology market, 2021 - 2033 (USD Million)
  • Fig. 26 Genetic diseases market, 2021 - 2033 (USD Million)
  • Fig. 27 Others market, 2021 - 2033 (USD Million)
  • Fig. 28 Medical devices market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 End use market, 2021 - 2033 (USD Million)
  • Fig. 31 Home care market, 2021 - 2033 (USD Million)
  • Fig. 32 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 33 Clinical laboratories market, 2021 - 2033 (USD Million)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Precision medicine market revenue, by region
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. country dynamics
  • Fig. 39 U.S. Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 40 Canada country dynamics
  • Fig. 41 Canada Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico country dynamics
  • Fig. 43 Mexico Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 45 UK country dynamics
  • Fig. 46 UK Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 47 Germany country dynamics
  • Fig. 48 Germany Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 49 France country dynamics
  • Fig. 50 France Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 51 Italy country dynamics
  • Fig. 52 Italy Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 53 Spain country dynamics
  • Fig. 54 Spain Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 55 Norway country dynamics
  • Fig. 56 Norway Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden country dynamics
  • Fig. 58 Sweden Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark country dynamics
  • Fig. 60 Denmark Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 62 Japan country dynamics
  • Fig. 63 Japan Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 64 China country dynamics
  • Fig. 65 China Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 66 India country dynamics
  • Fig. 67 India Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 68 Australia country dynamics
  • Fig. 69 Australia Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea country dynamics
  • Fig. 71 South Korea Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 72 Thailand country dynamics
  • Fig. 73 Thailand Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 74 Latin America Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 75 Brazil country dynamics
  • Fig. 76 Brazil Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 77 Argentina country dynamics
  • Fig. 78 Argentina Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 79 MEA Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa country dynamics
  • Fig. 81 South Africa Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia country dynamics
  • Fig. 83 Saudi Arabia Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 84 UAE country dynamics
  • Fig. 85 UAE Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait country dynamics
  • Fig. 87 Kuwait Precision medicine market, 2021 - 2033 (USD Million)
  • Fig. 88 Company categorization
  • Fig. 89 Company market position analysis
  • Fig. 90 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!